`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`Mylan Pharmaceuticals Inc., Petitioner
`
`v.
`
`Nissan Chemical Industries Ltd.
`Patent Owner
`
`U.S. Patent No. 5,856,336 to Fujikawa et al.
`Issue Date: January 5, 1999
`Title: Quinoline Type Mevalonolactones
`
`_____________________
`
`Inter Partes Review No.: IPR2015-01069
`__________________
`
`
`
`PETITIONER’S POWER OF ATTORNEY PURSUANT TO 37 C.F.R.
`§ 42.10(b) FOR INTER PARTES REVIEW OF
`U.S. PATENT NO. 5,856,336
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`Alston & Bird LLP
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.10(b), Mylan Pharmaceuticals Inc.,
`
`(“Petitioner”) hereby appoints the practitioners associated with Alston &
`
`Bird LLP Customer Number 00826, including the following lead and backup
`
`counsel, as its attorneys to transact all business in the United States Patent &
`
`Trademark Office associated with the above-captioned Petition for Inter
`
`Partes Review of U.S. Patent No. 5,856,336 on behalf of Petitioner:
`
`
`
`Lead Counsel
`Jitendra Malik
`Reg. No. 55823
`ALSTON & BIRD LLP
`4721 Emperor Blvd., Suite 400
`Durham, North Carolina 27703
`
`
`Back-Up Counsel
`Deanne M. Mazzochi
`Reg. No. 50158
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 West Hubbard St., Suite 500
`Chicago, Illinois 60654
`
`
`
`
`
`Alston & Bird LLP
`
`2
`
`
`
`
`
`
`
`Alston & Bird LLP
`Alston & Bird LLP
`
`3